Korro Bio updates corporate presentation for J.P. Morgan Healthcare Conference; no specific financial data disclosed

Korro Bio, Inc.

Corporate presentation updated as of January 9, 2024, for use in investor meetings.
Presentation filed as Exhibit 99.1 to Form 8-K; no material changes to financial outlook or pipeline disclosed in filing.
Event is a routine update for a healthcare conference; no new guidance, partnerships, or regulatory milestones announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.